Soluble PD-1 and PD-L1 as potential biomarkers for classical Hodgkin lymphoma

被引：11
|
作者：
da Silva, Priscilla Brito [1 ]
Real, Juliana Monte [2 ,3 ,4 ]
Pinto Ferreira, Ludmila Rodrigues [5 ]
Esteves, Gustavo H. [6 ]
Brito, Fabio do Nascimento [1 ]
Baiocchi, Otavio C. G. [1 ,7 ]
机构：
[1] Univ Fed Sao Paulo, UNIFESP, Dept Oncol Clin & Expt, Sao Paulo, Brazil
[2] Inst Canc Estado Sao Paulo, Ctr Invest Translac Oncol, Sao Paulo, Brazil
[3] Hosp Serv Publ Estadual Sao Paulo, IAMSPE, Sao Paulo, Brazil
[4] Hosp Santa Marcelina, Assoc TUCCA Criancas & Adolescentes Com Canc, Dept Oncol Pediat, Sao Paulo, Brazil
[5] Univ Fed Minas Gerais, ICB UFGM, Inst Ciencias Biol, Dept Morphol, Belo Horizonte, MG, Brazil
[6] Univ Estadual Paraiba, UEPB, Dept Estat, Campina Grande, Brazil
[7] HAOC, Hematol Div, Sao Paulo, Brazil
来源：
HEMATOLOGICAL ONCOLOGY | 2018年 / 36卷 / 04期
基金：
巴西圣保罗研究基金会;
关键词：
DEATH-LIGAND; 1; MICROENVIRONMENT; EXPRESSION;
D O I：
10.1002/hon.2542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：709 / 712
页数：4
相关论文
共 50 条
  • [1] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [2] Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
    Hollander, Peter
    Amini, Rose-Marie
    Ginman, Beatrice
    Molin, Daniel
    Enblad, Gunilla
    Glimelius, Ingrid
    PLOS ONE, 2018, 13 (09):
  • [3] THE NEUTROPHIL PD-L1 AND LYMPHOCYTE PD-1 AXIS IN THE PERIPHERAL BLOOD IN CLASSICAL HODGKIN LYMPHOMA
    Cuccaro, A.
    Zangrilli, I.
    Corrente, F.
    Cupelli, E.
    Fatone, F.
    Galli, E.
    Annunziata, S.
    Rufini, V.
    Balducci, M.
    D'Alo, F.
    Bellesi, S.
    De Stefano, V.
    Hohaus, S.
    HAEMATOLOGICA, 2018, 103 : S121 - S122
  • [4] Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomas
    Dilly-Feldis, Marie
    Aladjidi, Nathalie
    Refait, John K.
    Parrens, Marie
    Ducassou, Stephane
    Rullier, Anne
    PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
  • [5] The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma
    Ozturk, Vedia
    Yikilmaz, Aysun Senturk
    Kilicarslan, Aydan
    Bakanay, Sule Mine
    Akinci, Sema
    Dilek, Imdat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07): : E375 - E381
  • [6] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [7] Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma
    Feng, Xia
    Luo, Xiangyi
    Yang, Yingmei
    Fan, Yuchen
    Ye, Qing
    MEDICINE, 2023, 102 (44) : E35757
  • [8] Biomarkers of response to PD-1/PD-L1 inhibition
    Vareki, Saman Maleki
    Garrigos, Carmen
    Duran, Ignacio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 116 : 116 - 124
  • [9] Changes in PD-1 and PD-L1 Expression in Cases with Hodgkin Lymphoma after Chemotherapy
    Paydas, Semra
    Bagir, Emine
    Ergin, Melek
    Seydaoglu, Gulsah
    BLOOD, 2015, 126 (23)
  • [10] PD-L1 Expression in Classical Hodgkin Lymphoma in Pediatric Patients
    Aoki, Takahiro
    Kyushiki, Masashi
    Kishimoto, Hiroshi
    Yanagi, Masato
    Mori, Makiko
    Arakawa, Yuki
    Hino, Moeko
    Shimojo, Naoki
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S102 - S102
12345